Given the reduced tumorigenic and metastatic power of ARHGEF17-knockdown cells (Fig. 1, E–I), we explored the cellular and molecular mechanisms by which ARHGEF17 might play a critical role in lung cancer. Here, ARHGEF17 is linked to lung carcinoma.